Twist Bioscience | Twist Bioscience to Present at the Evercore ISI HealthCONx Conference

Press Release Details

Twist Bioscience to Present at the Evercore ISI HealthCONx Conference

Nov 27, 2018

SAN FRANCISCO--(BUSINESS WIRE)--Nov. 27, 2018-- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that Emily Leproust, Ph.D., chief executive officer, will participate in an analyst-led fireside chat at the Evercore ISI HealthCONx Conference on Thursday, November 29, 2018 at 8:45am Eastern Time at the Boston Harbor Hotel in Boston, MA.

This presentation will be webcast live and can be accessed by visiting the “Presentations” page of the investor relations section of the company's website at https://investors.twistbioscience.com/events-and-presentations/presentations. A replay of the presentation will be archived for a period of 90 days following the conclusion of the live event.

About Twist Bioscience Corporation

We are leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn